鼻咽癌患者调强放疗后慢性鼻窦炎:一项Meta分析
该Meta分析纳入9项研究(n=1478),评估鼻咽癌患者调强放疗(IMRT)后慢性鼻窦炎(CRS)的发生率和严重程度。无既往鼻窦炎的患者IMRT后发生CRS的可能性显著增加,而有既往鼻窦炎的患者因天花板效应比值降低(IMRT前100%已有CRS)。两组IMRT前后CRS严重程度均显著增加,Lund-Kennedy(LK)和Lund-Mackay(LM)评分变化最明显。
要点
- 鼻咽癌患者IMRT后CRS发生率和严重程度均显著增加。
- 无既往鼻窦炎者IMRT后发生CRS的可能性显著增加。
- 有既往鼻窦炎者因天花板效应(IMRT前100%已有CRS)比值降低。
核心结论
- 鼻咽癌患者IMRT后CRS发生率和严重程度均显著增加,临床医生应认识IMRT后CRS风险并建议降低CRS发生可能性的选项。
研究设计与样本
- 检索PubMed、CINAHL、Embase、Cochrane Library、Web of Science数据库2000年以来发表的研究,纳入按EPOS 2020验证方法(LM CT评分、LK内镜评分、SNOT问卷)评估鼻咽癌IMRT后CRS的研究,使用SPSS和R进行Meta分析。
- 共纳入9项研究,n=1478。
主要发现
- 无既往鼻窦炎的患者IMRT后发生CRS的可能性显著增加。
- 有既往鼻窦炎的患者因天花板效应(IMRT前100%已有CRS)比值降低。
- 两组IMRT前后CRS严重程度均显著增加,LK和LM评分方法变化最明显。
临床怎么用
- 临床医生应认识鼻咽癌患者IMRT后CRS风险,并建议降低CRS发生可能性的选项。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC) can cause chronic rhinosinusitis (CRS), an underexplored side effect. This review aimed to determine the incidence and severity of CRS in NPC patients post-IMRT. METHODS: Electronic databases (PubMed, CINAHL, Embase, Cochrane Library, Web of Science) were searched for studies published from 2000 onwards. Eligible studies assessed CRS in NPC patients post-IMRT, using validated methods per EPOS 2020 (Lund-Mackay (LM) CT scoring, Lund-Kennedy (LK) endoscopic scoring, SNOT questionnaire). Meta-analysis was conducted using SPSS and R to quantify pooled CRS incidence and severity. RESULTS: Nine studies (n=1,478) were included, revealing distinct patterns in CRS development and severity. Patients without prior sinusitis showed significantly increased likelihood of developing CRS post-IMRT, while those with prior sinusitis had reduced odds due to a ceiling effect, as CRS was already present in 100% of these patients before IMRT. Both groups showed significant increases in CRS severity pre- and post-IMRT, with the LK and LM scoring methods showing the most substantial changes. CONCLUSIONS: This review underscores the significant increases in both the incidence and severity of CRS in NPC patients post- IMRT. Clinicians should recognise the risk of CRS post-IMRT and recommend options to reduce the likelihood of CRS development.
引用
- Chua NYM, Lau WK, Chui AL, et al. Chronic rhinosinusitis in nasopharyngeal carcinoma patients post- IMRT: a meta-analysis. Rhinology. 2025. PMID: 40406956. doi:10.4193/Rhin25.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。